Drug intelligence / Profile preview

Terafluxx

Development stage: Unknown
Lead developer: Ruhrpharm
Modality: Small Molecules
Administration: Oral

Overview

Terafluxx is a nutraceutical supplement developed by Ruhrpharm, specifically formulated to support male fertility and reproductive health. The product contains a combination of two essential trace minerals: zinc and selenium. Zinc is a critical cofactor for numerous enzymes involved in DNA synthesis and cell division, and it is essential for maintaining normal serum testosterone levels. Selenium is a key component of selenoproteins, such as glutathione peroxidase, which provide antioxidant protection to sperm cells and are necessary for normal spermatogenesis and sperm motility. Terafluxx is marketed as a dietary management option for men to optimize the micronutrient environment required for healthy sperm production.

Brand names: Terafluxx

Targets

SELENOS (Selenoprotein S)

Beyond the preview

Go deeper on Terafluxx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terafluxx.

Explore the full profile